Co-regulation of the transcription controlling ATF2 phosphoswitch by JNK and p38

[1]  A. Nebreda.  Faculty Opinions recommendation of Co-regulation of the transcription controlling ATF2 phosphoswitch by JNK and p38. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[2]  W. Kolch,et al.  Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity , 2020, International journal of molecular sciences.

[3]  William S. Hlavacek,et al.  PyBioNetFit and the Biological Property Specification Language , 2019, iScience.

[4]  K. Lindorff-Larsen,et al.  Dynamic activation and regulation of the mitogen-activated protein kinase p38 , 2018, Proceedings of the National Academy of Sciences.

[5]  Matthias Bethge,et al.  Signatures of criticality arise from random subsampling in simple population models , 2016, PLoS Comput. Biol..

[6]  Z. Ronai,et al.  ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease , 2017, Pharmacological research.

[7]  Matthew J. Betts,et al.  Systematic identification of phosphorylation-mediated protein interaction switches , 2017, PLoS Comput. Biol..

[8]  Paul A. Bates,et al.  Opposing effects of Elk-1 multisite phosphorylation shape its response to ERK activation , 2016, Science.

[9]  A. Reményi,et al.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships , 2016, Microbiology and Molecular Reviews.

[10]  Zhi-Xin Wang,et al.  A conserved motif in JNK/p38-specific MAPK phosphatases as a determinant for JNK1 recognition and inactivation , 2016, Nature Communications.

[11]  G C P van Zundert,et al.  The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes. , 2016, Journal of molecular biology.

[12]  Brock F. Binkowski,et al.  NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells. , 2016, ACS chemical biology.

[13]  Dipak Barua,et al.  BioNetGen 2.2: advances in rule-based modeling , 2015, Bioinform..

[14]  Zsuzsanna Dosztányi,et al.  Systematic discovery of linear binding motifs targeting an ancient protein interaction surface on MAP kinases , 2015, Molecular systems biology.

[15]  Hsin Wang,et al.  Structural and Dynamic Features of F-recruitment Site Driven Substrate Phosphorylation by ERK2 , 2015, Scientific Reports.

[16]  E. Choi,et al.  Compromised MAPK signaling in human diseases: an update , 2015, Archives of Toxicology.

[17]  Woonghee Lee,et al.  NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy , 2014, Bioinform..

[18]  S. Knapp,et al.  Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate Recognition , 2013, Structure.

[19]  O. Livnah,et al.  DEF Pocket in p38α Facilitates Substrate Selectivity and Mediates Autophosphorylation* , 2013, The Journal of Biological Chemistry.

[20]  A. Reményi,et al.  Structural Mechanism for the Specific Assembly and Activation of the Extracellular Signal Regulated Kinase 5 (ERK5) Module , 2013, The Journal of Biological Chemistry.

[21]  O. Livnah,et al.  Lipid molecules induce p38α activation via a novel molecular switch. , 2012, Journal of molecular biology.

[22]  Jerome C Nwachukwu,et al.  Structural mechanisms of allostery and autoinhibition in JNK family kinases. , 2012, Structure.

[23]  Hagen Blankenburg,et al.  Specificity of Linear Motifs That Bind to a Common Mitogen-Activated Protein Kinase Docking Groove , 2012, Science Signaling.

[24]  Günter P. Wagner,et al.  Regulatory evolution through divergence of a phosphoswitch in the transcription factor CEBPB , 2011, Nature.

[25]  Nathaniel Echols,et al.  The Phenix software for automated determination of macromolecular structures. , 2011, Methods.

[26]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[27]  E. Wagner,et al.  Signal integration by JNK and p38 MAPK pathways in cancer development , 2009, Nature Reviews Cancer.

[28]  Kevin N. Dalby,et al.  Substrate Discrimination among Mitogen-activated Protein Kinases through Distinct Docking Sequence Motifs* , 2008, Journal of Biological Chemistry.

[29]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[30]  D. Gründemann,et al.  Fast set‐up of doxycycline‐inducible protein expression in human cell lines with a single plasmid based on Epstein–Barr virus replication and the simple tetracycline repressor , 2007, The FEBS journal.

[31]  J. Marsh,et al.  Sensitivity of secondary structure propensities to sequence differences between α‐ and γ‐synuclein: Implications for fibrillation , 2006 .

[32]  Jian Jian Li,et al.  Mutual regulation of c‐Jun and ATF2 by transcriptional activation and subcellular localization , 2006, The EMBO journal.

[33]  S. Ishii,et al.  Drosophila activating transcription factor-2 is involved in stress response via activation by p38, but not c-Jun NH(2)-terminal kinase. , 2005, Molecular biology of the cell.

[34]  Edward M. Rosser,et al.  Synthetic anisomycin analogues activating the JNK/SAPK1 and p38/SAPK2 pathways. , 2004, Organic & biomolecular chemistry.

[35]  P. Cohen,et al.  Signalling pathways involved in multisite phosphorylation of the transcription factor ATF‐2 , 2004, FEBS letters.

[36]  E. Goldsmith,et al.  Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry. , 2004, Molecular cell.

[37]  A. Shevchenko,et al.  Transcription Control by E1A and MAP Kinase Pathway via Sur2 Mediator Subunit , 2002, Science.

[38]  L. Mahadevan,et al.  Transcription: MAPK-regulated transcription: a continuously variable gene switch? , 2002, Nature Reviews Molecular Cell Biology.

[39]  L. Kay,et al.  Ligand-induced structural changes to maltodextrin-binding protein as studied by solution NMR spectroscopy. , 2001, Journal of molecular biology.

[40]  Kevin N. Dalby,et al.  The Kinetic Mechanism of the Dual Phosphorylation of the ATF2 Transcription Factor by p38 Mitogen-activated Protein (MAP) Kinase α , 2001, The Journal of Biological Chemistry.

[41]  A. Sharrocks,et al.  Docking domains and substrate-specificity determination for MAP kinases. , 2000, Trends in biochemical sciences.

[42]  R. Davis,et al.  Regulation of transcription factor function by phosphorylation , 2000, Cellular and Molecular Life Sciences CMLS.

[43]  K. Dalby,et al.  The Kinetic Mechanism of the Dual Phosphorylation of the ATF2 Transcription Factor by p38 MAP kinase a : Implications for Signal/Response profiles of MAP Kinase pathways. , 2000 .

[44]  M. Verlaan,et al.  The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A , 1999, Oncogene.

[45]  S. Ishii,et al.  Solution structure of the transactivation domain of ATF-2 comprising a zinc finger-like subdomain and a flexible subdomain. , 1999, Journal of molecular biology.

[46]  K Kornfeld,et al.  Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. , 1999, Genes & development.

[47]  P. Russell,et al.  Conjugation, meiosis, and the osmotic stress response are regulated by Spc1 kinase through Atf1 transcription factor in fission yeast. , 1996, Genes & development.

[48]  R. Davis,et al.  MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.

[49]  R. Sidman,et al.  Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice , 1996, Nature.

[50]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[51]  N. Jones,et al.  ATF‐2 contains a phosphorylation‐dependent transcriptional activation domain. , 1995, The EMBO journal.

[52]  B. Dérijard,et al.  Transcription factor ATF2 regulation by the JNK signal transduction pathway , 1995, Science.

[53]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[54]  J. Blenis,et al.  Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[55]  M. Karin,et al.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. , 1993, Genes & development.

[56]  D. Edwards,et al.  Protein synthesis inhibitors differentially superinduce c‐fos and c‐jun by three distinct mechanisms: lack of evidence for labile repressors. , 1992, The EMBO journal.

[57]  M. Karin,et al.  Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73 , 1991, Nature.

[58]  S. Iijima.  Helical microtubules of graphitic carbon , 1991, Nature.